BioTech

Investment in rare disease BioTechs has increased following renewal of the FDA’s Priority Review Voucher (PRV) programme, according to SynaptixBio, but the United States remains dominant compared to the UK. In...

GSK has announced plans to establish a major new global R&D centre in Cambridge, UK, as part of the company’s plan to accelerate its R&D pipeline. The new 300,000 square foot site, on the Cambridge Biomedical Campus i...

Caidya has announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a...

Membrane Translocation Domain (MTD) platform demonstrates a potential solution to one of biotechnology’s most persistent challenges by delivering therapeutic proteins inside cells. Permeasis Therapeutics, a...

Classiq and Pontificia Universidad Católica de Chile (UC Chile) have announced a joint research project to develop hybrid quantum algorithms for biomedical image analysis – assisted by classical machine learning ...

A laboratory at the Tulane University School of Medicine has enhanced its drug screening and tumour modelling workflows by adopting advanced liquid handling solutions from INTEGRA Biosciences, including the PIPETBOY...